Bring a genuine donor
International patients should not expect a hospital or intermediary to source a living donor. Organ payment and coercion are unacceptable.
Kidney transplant cost in Turkey
An international kidney-transplant estimate must cover two independent patients: recipient and living donor. It should separate compatibility testing, donor safety, relationship and ethics documents, two operations, pathology, ICU and ward limits, rejection and infection treatment, immunosuppressive medicines, and a durable home follow-up plan. A commercial donor offer is a stop signal, not a shortcut.
How much does kidney transplant cost in Turkey?
A planned living-donor kidney transplant in Turkey is commonly budgeted at TRY 1,175,000 to 2,350,000 (about USD 25,000 to 50,000) for recipient and donor hospital care. Complex compatibility, vascular reconstruction, prolonged dialysis, rejection, infection, ICU care, donor complications, or readmission can raise the total above TRY 2,820,000 (about USD 60,000).
USD examples use about TRY 47 per USD near the official 17 July 2026 indicative rate. Confirm whether TRY, EUR, or USD controls the package, long-term imported medicines, deposits, and refunds.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-19
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: TRY and USD
International patients should not expect a hospital or intermediary to source a living donor. Organ payment and coercion are unacceptable.
Turkey’s 2022 regulation describes spouse and family pathways and ethics review for other living-donor situations; foreign cases can receive additional scrutiny or restriction.
A donor-rights advocate, informed consent, psychosocial assessment, and long-term health plan should protect the donor apart from recipient pressure.
Immunosuppression, laboratory monitoring, infection prevention, vaccination, and graft surveillance continue permanently.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | TRY | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Compatible related living donor | TRY 1,175,000 - 1,645,000 | USD 25,000 - 35,000 | Medically suitable recipient and donor with documented permitted relationship, compatible testing, and straightforward anatomy. | Should price both workups, ethics and coordination, donor nephrectomy, recipient implant, stated stays, and early follow-up. |
| Complex compatibility or anatomy | TRY 1,645,000 - 2,350,000 | USD 35,000 - 50,000 | Sensitization, additional immune testing, difficult vessels, obesity, prior transplant, or higher donor and recipient evaluation needs. | Requires procedure, medicine, blood, dialysis, and critical-care assumptions tailored to the case. |
| Complication or prolonged recovery | TRY 2,350,000 - 2,820,000+ | USD 50,000 - 60,000+ | Delayed graft function, rejection, infection, re-operation, ICU, donor complication, or readmission. | Not safely represented by the routine package; request unit and daily rates. |
Usually included
Kidney-failure cause, cardiac and infection safety, vascular anatomy, cancer screening, blood group, HLA, and antibodies.
Define repeat and advanced immune tests.
Independent kidney, medical, surgical, psychosocial, infection, anatomy, and consent review.
The donor needs a separate care plan and invoice scope.
Donor nephrectomy, recipient implantation, anesthesia, theatre, specified ICU and ward days.
Get both overstay rates.
Routine labs, ultrasound, drug levels, discharge medicines, and scheduled reviews.
Biopsy or rejection therapy may be separate.
Confirm separately
Translation, apostille, embassy verification, extra interviews, or rescheduled surgery.
Do not book surgery before written acceptance.
Apheresis, immunoglobulin, special immune medicines, and repeated antibody tests.
Obtain a separate protocol price.
Dialysis, biopsy, plasma exchange, high-cost therapy, ICU, or extended admission.
Ask for scenario billing.
Immunosuppressants, graft tests, donor monitoring, lodging, transport, and home specialists.
Budget beyond surgery.
Candidate context
Kidney transplant can improve survival and quality of life for many suitable people with irreversible kidney failure, but candidacy depends on cardiovascular safety, infection and cancer status, vascular anatomy, adherence, psychosocial support, and a lawful medically suitable donor pathway. Dialysis and urgent complications must remain safely managed while legal and clinical review proceeds. The donor must be free to withdraw confidentially at any time.
Cardiac, vascular, infection, malignancy, nutrition, frailty, urology, and adherence factors are reviewed before immunosuppression.
Kidney function, blood pressure, metabolic risk, anatomy, mental health, family context, and lifetime implications are assessed independently.
Blood group, HLA, antibody screen, crossmatch, and previous transfusion, pregnancy, or transplant history shape immune risk.
Identity, relationship, marriage, birth, residence, income, and other documents may be reviewed and translated for ethics assessment.
Hemodialysis or peritoneal dialysis remains essential while evaluating candidacy, donor, infection, or finances.
Some incompatible donor-recipient pairs may be considered for an authorized exchange pathway; international eligibility must be confirmed.
Cardiac treatment, weight, infection, vaccination, cancer clearance, adherence, or vascular planning may need attention first.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
A qualifying family or spouse pathway with documented relationship and independent donor clearance.
Foreign cases still require center and authority acceptance.
May require formal ethics review and extensive evidence of a genuine non-commercial relationship.
Never assume approval.
Common minimally invasive retrieval approach when anatomy and expertise permit.
Conversion and donor complication terms matter.
Selected programs may consider immune-risk reduction or exchange after detailed review.
Cost, risk, and eligibility differ substantially.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Istanbul | TRY 1,316,000 - 2,585,000 | USD 28,000 - 55,000 | Broad transplant and international coordination choice. | Budget two travelers and long follow-up. |
| Ankara | TRY 1,269,000 - 2,444,000 | USD 27,000 - 52,000 | Strong academic and tertiary transplant services. | Confirm foreign-case pathway. |
| Izmir | TRY 1,175,000 - 2,350,000 | USD 25,000 - 50,000 | Established renal transplant options. | Verify donor and ethics timing. |
| Antalya | TRY 1,269,000 - 2,444,000 | USD 27,000 - 52,000 | Selected international private pathways. | Confirm transplant license. |
| Bursa | TRY 1,128,000 - 2,209,000 | USD 24,000 - 47,000 | Potential value at qualified centers. | Do not infer capability citywide. |
| Kocaeli and Gebze | TRY 1,175,000 - 2,350,000 | USD 25,000 - 50,000 | Marmara tertiary access. | Budget donor transport. |
| Adana | TRY 1,128,000 - 2,209,000 | USD 24,000 - 47,000 | Selected regional transplant centers. | Verify current international intake. |
| Konya | TRY 1,081,000 - 2,115,000 | USD 23,000 - 45,000 | Case-specific authorized availability. | Compare ICU and nephrology depth. |
| Kayseri | TRY 1,081,000 - 2,115,000 | USD 23,000 - 45,000 | Selected tertiary evaluation. | Plan dialysis backup. |
| Gaziantep | TRY 1,034,000 - 2,068,000 | USD 22,000 - 44,000 | Program-level verification essential. | Require ethics acceptance before travel. |
Estimate variables
Recipient and donor diagnostics, imaging, specialists, and documentation are separate.
Price both.
Antibodies, crossmatch, incompatible blood group, and prior sensitization add tests and therapy.
Use current samples.
Vascular anatomy, delayed function, dialysis, biopsy, or re-operation changes admission.
Request escalation rates.
Drug selection, levels, rejection, infection, and home availability determine ongoing cost.
Confirm supply before return.
Medical cost breakdown
Cardiac, vascular, infection, cancer, kidney, urology, and immune testing.
Old tests may repeat.
Kidney function, imaging, medical, surgical, psychosocial, and infectious review.
Protect donor privacy.
Certified identities, relationship evidence, translations, and committee process.
Confirm exact current list.
Nephrectomy, anesthesia, room, pain care, and follow-up.
Separate donor complications.
Implant, anesthesia, ICU or ward, ultrasound, labs, and routine medicines.
State days and caps.
Dialysis, biopsy, rejection, infection, vascular intervention, or ICU.
Usually additional.
Creatinine, drug levels, ultrasound, blood counts, infection, and rejection review.
Frequent early visits.
Wound, kidney function, blood pressure, pain, and long-term health review.
Do not end at discharge.
Immunosuppression, prophylaxis, vaccines, and chronic-risk management.
Budget lifelong access.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Two flexible flight plans, baggage, and assistance.
Donor clearance can change dates.
Accessible stay near transplant and dialysis services.
Allow separate recovery needs.
Dialysis, extra testing, delayed surgery, readmission, and changed flights.
Keep substantial funds.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Turkey’s organ-transplant regulation sets relationship and ethics-review pathways; obtain written center guidance for foreign recipient and donor before travel.
Foreign cases and applicants from areas identified as higher risk may face mandatory review or restrictions even when related.
Do not pay a donor or accept donor sourcing. Suspicious payment, coercion, or document fabrication should end the process.
Verify organ-specific Ministry activity permission plus international-health-tourism authorization.
Check entry rules for recipient and donor through government channels before committing funds.
Hospital selection
Current kidney-transplant activity, international authorization, and transparent adult or pediatric scope.
Verify directly.
Independent advocate, confidential withdrawal, psychosocial review, ethics process, and long-term follow-up.
Recipient convenience is secondary.
Nephrology, dialysis, immunology, pathology, infection, ICU, blood bank, radiology, and re-operation.
Available around the clock.
Recipient, graft, donor, rejection, infection, and readmission results with timeframe and denominator.
Avoid universal success claims.
Treating team
Assesses recipient, immune risk, graft function, medicines, rejection, and long-term care.
Plan donor safety, retrieval, recipient vascular implantation, and surgical complications.
Supports compatibility, biopsy, rejection, and infection management.
Protects voluntary consent and manages lawful documentation without promising approval.
Treatment timeline
Review recipient, donor, relationship, compatibility, dialysis, and documents before booking.
Both patients complete separate medical, psychosocial, surgical, and legal assessment.
Surgery proceeds only after required approval, updated compatibility, and two informed consents.
Donor retrieval and recipient transplant are coordinated with independent safety oversight.
Kidney function, drug levels, infection, wound, blood pressure, and complications are monitored.
Home teams receive operative, donor, pathology, immune, medicine, laboratory, and emergency plans.
Risks and edge cases
The transplant must stop or change without pressure on the donor.
Ask cancellation terms.
Recipient may need dialysis and longer admission.
Price dialysis separately.
Biopsy, high-dose or specialized therapy, and hospitalization may be required.
Know emergency contacts.
Thrombosis, bleeding, leak, or obstruction may need intervention or surgery.
Verify rescue services.
Interrupted immunosuppression risks graft loss.
Secure supply and alternatives before travel.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Donor law | Living donation follows Indian relationship and authorization rules. | Relationship, ethics, and foreign-case provisions apply under Turkish regulation. | Strict national transplant and donor eligibility rules require direct confirmation. | Obtain written legal acceptance before travel. |
| Program choice | Many high-volume renal programs across metros. | Strong tertiary programs with geographic access for Europe and nearby regions. | Fewer international living-donor options concentrated in major centers. | Compare donor protection and graft care. |
| Long-term cost | Medicines and tests may be lower-cost but vary by city. | Imported drug and currency exposure can affect follow-up. | Private follow-up can be comparatively costly. | Model lifelong medicines in the home country. |
Decision guidance
Recipient and genuine donor receive written preliminary acceptance from an authorized center with clear ethics, two-patient, dialysis, and follow-up scope.
Anyone offers a donor, requests donor payment, promises ethics approval, minimizes donor testing, or advises false relationship documents.
Do not interrupt dialysis or urgent local treatment while awaiting review, visas, documents, or surgery.
Reports for review
Create separate recipient and donor files. Include identity and certified relationship evidence, complete kidney and dialysis history, cardiac and infection records, immune tests and sensitizing events, donor health and imaging, medicines, and receiving home nephrologist details.
Upload medical reportsProvide the complete kidney diagnosis and dialysis records as a readable record for clinical and cost review.
Provide the complete cardiac, vascular, cancer and infection tests as a readable record for clinical and cost review.
Provide the complete blood group, hla, antibodies and crossmatch as a readable record for clinical and cost review.
Provide the complete medicines, transfusions, pregnancies and prior transplant as a readable record for clinical and cost review.
Provide the complete identity and relationship documents as a readable record for clinical and cost review.
Provide the complete kidney function, blood pressure and metabolic tests as a readable record for clinical and cost review.
Provide the complete ct donor angiography when performed as a readable record for clinical and cost review.
Provide the complete independent medical and psychosocial reports as a readable record for clinical and cost review.
Provide the complete home dialysis and nephrologist contacts as a readable record for clinical and cost review.
Provide the complete passport, visa and translation plan as a readable record for clinical and cost review.
Provide the complete medicine availability and insurance as a readable record for clinical and cost review.
Provide the complete caregiver and local-stay plan as a readable record for clinical and cost review.
Common questions
A legitimate provider should not sell or source a living organ. The patient must present a lawful genuine donor for independent evaluation.
A non-standard relationship may require ethics review and extensive evidence; foreign-case eligibility must be confirmed in writing.
Only if stated. Ask for medical, imaging, psychosocial, immune, legal, surgery, admission, complication, and follow-up scope.
Do not assume international access to a national deceased-donor list. Obtain current written advice from an authorized transplant center and authority.
The team may decline, explore authorized exchange, or discuss a specialized immune-risk pathway with different cost and risk.
Dialysis may continue before surgery and can be needed after transplant if graft function is delayed.
Donor and recipient timelines differ; the center should set both from recovery, graft function, medicines, and complications.
Initial inpatient medicines may be included, but lifelong supply usually is not. Confirm exact discharge quantities.
Yes. Voluntary donation requires the ability to withdraw without coercion and with confidentiality.
Carry donor and recipient operation notes, pathology, immune results, labs, imaging, medicines, follow-up schedule, and urgent contacts.
Review and sources
The range models recipient and donor as separate care pathways, then adds compatibility, legal review, surgery, early graft monitoring, and complication exposure. Current Turkish transplant regulation and ethical principles were treated as gating requirements, not footnotes. Conversion is anchored near 17 July 2026; only written acceptance and a two-patient estimate can establish an individual budget.
This guide cannot establish transplant eligibility, donor legality, ethics approval, compatibility, prognosis, or travel fitness. Never buy an organ or falsify a relationship. Continue prescribed dialysis and obtain urgent local care for breathing difficulty, chest pain, severe weakness, fever, confusion, low urine output, or dialysis-access problems.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Living donor relationships, ethics review, donor advocate, licensing, and follow-up.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Current amendment context.
Declaration of Istanbul Custodian Group · Accessed 2026-07-19
Supports: Ethical travel, self-sufficiency, organ trafficking, and commercialism principles.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: International service framework.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Provider verification.
Central Bank of the Republic of Turkey via e-Government Gateway · Accessed 2026-07-19
Supports: Conversion context.
Related planning
Compare another living-donor pathway.
Review cellular transplantation.
Plan cardiac optimization.
Compare another regulated destination.
Understand recipient and donor stages.
Compare transplant capability.
Review surgical team selection.
Plan kidney and dialysis care.
Organize two files.
Request staged pricing.
Questions about an estimate? Email support@virellohealth.com.